Chlamydia trachomatis infection in women living in remote areas in Amazonas, Brazil-a self-collection screening experience

Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Editora
SAGE PUBLICATIONS LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
ROCHA, Danielle A. P.
MORAES, Cassia de Oliveira
ARAUJO, Adriene F.
BELTRAO, Emille dos Santos
SANTOS, Lainara Castelo dos
MATA, Ligia Menezes da
XAVIER, Antonio N. N.
REIS, Renato dos Santos
SOARES, Silvia C. C.
TORRES, Katia L.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF STD & AIDS, v.30, n.4, p.336-343, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Chlamydia trachomatis infection is the most common sexually transmitted bacterial infection among women. In Brazil, there is no organized screening program for C. trachomatis, and the actual prevalence of infection is unknown. This study aimed to determine the prevalence of C. trachomatis infection in women living in riverside communities in the Amazon, using self-collection employing the Evalyn (R) Brush and polymerase chain reaction. A total of 299 riverine women aged 18-81 years, mean age 35.7 (+/- 12.8) years, predominantly agricultural workers, with low schooling and living with a partner, participated in this study. The prevalence of C. trachomatis infection was found to be 3.7% (95% CI 1.8-6.5), most of them being symptomatic. The mean age of the first sexual intercourse reported by women was 15.2 (+/- 2.3) years, and the majority reported having had none or only one partner in the last 12 months, with very low adherence to consistent condom use (15.4%). Most women (98.3%) reported having approved using the vaginal self-collecting brush, and only 4.7% reported having difficulty in handling the brush. We consider that a vaginal self-collecting device is adequate for diagnosing C. trachomatis infection in women living in remote, hard-to-reach areas.
Palavras-chave
Chlamydia (Chlamydia trachomatis), South America, epidemiology
Referências
  1. Barcelos MRB, 2008, REV BRAS GINECOL OBS, V30, P349, DOI 10.1590/S0100-72032008000700005
  2. BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x
  3. Brasiliense DM, 2016, J INFECT DEV COUNTR, V10, P134, DOI 10.3855/jidc.6474
  4. Cevenini R, 2002, BEST PRACT RES CL OB, V16, P761, DOI 10.1053/beog.2002.0323
  5. Chernesky M, 2014, J CLIN MICROBIOL, V52, P2305, DOI 10.1128/JCM.03552-13
  6. Conejero C, 2013, REV CHIL INFECTOL, V30, P489, DOI 10.4067/S0716-10182013000500004
  7. Machado MSC, 2012, BRAZ J INFECT DIS, V16, P188, DOI 10.1590/S1413-86702012000200015
  8. de Codes Jose Santiago, 2006, Cad Saude Publica, V22, P325
  9. Ejegod DM, 2018, PAPILLOMAVIRUS RES, V5, P192, DOI 10.1016/j.pvr.2018.04.005
  10. Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30
  11. Falk L, 2010, INT J STD AIDS, V21, P283, DOI 10.1258/ijsa.2009.009440
  12. Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010
  13. Fernandes AMS, 2009, REV BRAS GINECOL OBS, V31, P1
  14. Fonseca AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133635
  15. Gopalkrishna V, 2000, CLIN MICROBIOL INFEC, V6, P88, DOI 10.1046/j.1469-0691.2000.00024.x
  16. Guimaraes EMB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-8
  17. INCA. Instituto Nacional do Cancer Jose Gomes Alencar da Silva, 2016, EST 2016 INC CANC BR, P124
  18. Jalil EM, 2008, REV BRAS GINECOL OBS, V30, P614, DOI 10.1590/S0100-72032008001200005
  19. Luppi Carla Gianna, 2011, Rev. bras. epidemiol., V14, P467, DOI 10.1590/S1415-790X2011000300011
  20. Mishori R, 2012, AM FAM PHYSICIAN, V86, P1127
  21. Gama ASM, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00002817
  22. Neves D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00101015
  23. Piazzetta RCPS, 2011, REV BRAS GINECOL OBS, V33, P328, DOI 10.1590/S0100-72032011001100002
  24. Paudyal P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124310
  25. Rocha DAP, 2014, INT J STD AIDS, V25, P878, DOI 10.1177/0956462414523742
  26. Price MJ, 2016, HEALTH TECHNOL ASSES, V20, P282
  27. Santos Cristina, 2003, Braz J Infect Dis, V7, P91, DOI 10.1590/S1413-86702003000200001
  28. Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003
  29. Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790
  30. Tranberg M, 2018, CLIN EPIDEMIOL, V10, P1027, DOI 10.2147/CLEP.S164826
  31. Tranberg M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3254-y
  32. Witkin SS, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00203-17, 10.1128/cvi.00203-17]